David W.J. McGirr's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 7,037 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 7,037 | 7,037 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 4,712 | 4,712 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 4,000 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 4,000 | 7,000 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 1,500 | 4,722 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,431 | 0 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 03 Jun 2025 | 65,431 | 68,431 (0%) | 0% | 4.6 | 300,328 | Common Stock |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Sale of securities on an exchange or to another person at price $ 65.15 per share. | 03 Jun 2025 | 55,558 | 12,873 (0%) | 0% | 65.1 | 3,619,404 | Common Stock |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Sale of securities on an exchange or to another person at price $ 65.64 per share. | 03 Jun 2025 | 9,873 | 3,000 (0%) | 0% | 65.6 | 648,090 | Common Stock |
| Insmed Inc | David W.J. McGirr | Director | Sale of securities on an exchange or to another person at price $ 71.30 per share. | 03 Jun 2025 | 3,250 | 100,723 (0%) | 0% | 71.3 | 231,725 | Common Stock |
| Insmed Inc | David W.J. McGirr | Director | Sale of securities on an exchange or to another person at price $ 73.27 per share. | 03 Jun 2025 | 3,000 | 97,723 (0%) | 0% | 73.3 | 219,810 | Common Stock |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 5,058 | 103,973 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 3,000 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 3,000 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 4,000 | 4,000 | - | - | Restricted Stock Units | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 45,000 | 96,667 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 13,162 | 98,915 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 13,192 | 85,753 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 6,667 | 6,667 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 14,645 | 72,561 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| X4 Pharmaceuticals Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Insmed Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 7,558 | 57,916 (0%) | 0% | - | Common Stock |